Found 0 matching trials
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) PHASE1 This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders PHASE1 This study is testing a new type of treatment called anti-CD19 CAR-T cell t...
Show More Location
National Medical Research Center for Hematology
Learn More & Join Trial
RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies PHASE1 This is an open-label Phase 1 study to determine the feasibility, safety, a...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) PHASE1 This study is for patients who have lymphoma or leukemia that has come back...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
CD19/79b Bi-specific CAR-T Cell Therapy PHASE1 The purpose of this study is to assess the feasibility, safety and efficacy...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial
Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation EARLY_PHASE1 This is an open, single-arm, phase I/phase II clinical study to evaluate ef...
Show More Location
No.2 Hospital of Hebei Medical University
Learn More & Join Trial
Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma PHASE1 This phase I/II trial studies the side effects and best dose of genetically...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Immunotherapy in Lymphoma N/A The goal of this observational study is to compare the efficacy of advanced...
Show More Location
Seoul St. Mary Hospital
Learn More & Join Trial
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma PHASE1 This phase I trial studies the side effects and best dose of memory-enriche...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
CD19/70 Bi-specific CAR-T Cell Therapy PHASE1 The purpose of this study is to assess the feasibility, safety and efficacy...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial